BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 30, 2016
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-08-29$37.61/sh−1,607$60,440→ 978,571 total(indirect: See footnote) - Sale
Common Stock, $.001 par value
2016-08-30$37.50/sh−2,692$100,957→ 975,879 total(indirect: See footnote)
Footnotes (3)
- [F1]The selling price of $37.6107 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.51 to $37.625. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $37.5027 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.5005 to $37.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]These shares are held in trust on behalf of the reporting person and Ms. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.